Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 42.53 Delayed Data As of Jan 27 |  -2.08 / -4.66%Today’s Change | 18.70 Today|||52-Week Range 54.21 | -8.34% Year-to-Date |
Latest IOVA News | Press Releases
No recent news for Iovance Biotherapeutics Inc.
Today’s Trading
| Previous close | 44.61 |
| Today’s open | 44.00 |
| Day’s range | 41.09 - 44.92 |
| Volume | 185,198 |
| Average volume (3 months) | 1,410,207 |
| Market cap | $7.0B |
Data as of 4:00pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | -25.07% |
| Earnings growth (this year) | -16.14% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 20.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HALOHalozyme Therapeutic... | -1.72 | -3.54% |
| ---- | ||
| XLRNAcceleron Pharma Inc | -6.49 | -5.36% |
| KODKodiak Sciences Inc | -11.52 | -7.90% |
Data as of 3:59pm ET, 01/27/2021
Financials
| Next reporting date | March 3, 2021 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$197.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
